Literature DB >> 8114739

Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

M Meyerson1, E Harlow.   

Abstract

A family of vertebrate cdc2-related kinases has been identified, and these kinases are candidates for roles in cell cycle regulation. Here, we show that the human PLSTIRE gene product is a novel cyclin-dependent kinase, cdk6. The cdk6 kinase is associated with cyclins D1, D2, and D3 in lysates of human cells and is activated by coexpression with D-type cyclins in Sf9 insect cells. Furthermore, we demonstrate that endogenous cdk6 from human cell extracts is an active kinase which can phosphorylate pRB, the product of the retinoblastoma tumor suppressor gene. The activation of cdk6 kinase occurs during mid-G1 in phytohemagglutinin-stimulated T cells, well prior to the activation of cdk2 kinase. This timing suggests that cdk6, and by analogy its homolog cdk4, links growth factor stimulation with the onset of cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114739      PMCID: PMC358568          DOI: 10.1128/mcb.14.3.2077-2086.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

1.  Phosphorylation of the retinoblastoma protein by cdk2.

Authors:  T Akiyama; T Ohuchi; S Sumida; K Matsumoto; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Authors:  S Bates; L Bonetta; D MacAllan; D Parry; A Holder; C Dickson; G Peters
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

4.  TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Authors:  M E Ewen; H K Sluss; L L Whitehouse; D M Livingston
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

5.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

6.  Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.

Authors:  J Y Kato; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells.

Authors:  K Ando; F Ajchenbaum-Cymbalista; J D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

8.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

9.  Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.

Authors:  H Zhang; Y Xiong; D Beach
Journal:  Mol Biol Cell       Date:  1993-09       Impact factor: 4.138

10.  A family of human cdc2-related protein kinases.

Authors:  M Meyerson; G H Enders; C L Wu; L K Su; C Gorka; C Nelson; E Harlow; L H Tsai
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  242 in total

1.  The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

Authors:  L F van Dyk; J L Hess; J D Katz; M Jacoby; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line.

Authors:  Jiang Li; Xin-Ke Yang; Xin-Xin Yu; Meng-Liang Ge; Wen-Liang Wang; Jie Zhang; Yun-De Hou
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 3.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

4.  Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse.

Authors:  Soon-Kyung Hwang; Arash Minai-Tehrani; Hwang-Tae Lim; Ji-Young Shin; Gil-Hwan An; Kee-Ho Lee; Kee-Rang Park; Yeon-Soo Kim; George R Beck; Hsin-Sheng Yang; Myung-Haing Cho
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-10       Impact factor: 2.849

5.  Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.

Authors:  Gottfried E Konecny; Boris Winterhoff; Teodora Kolarova; Jingwei Qi; Kanthinh Manivong; Judy Dering; Guorong Yang; Meenal Chalukya; He-Jing Wang; Lee Anderson; Kimberly R Kalli; Richard S Finn; Charles Ginther; Siân Jones; Victor E Velculescu; Darren Riehle; William A Cliby; Sophia Randolph; Maria Koehler; Lynn C Hartmann; Dennis J Slamon
Journal:  Clin Cancer Res       Date:  2011-01-28       Impact factor: 12.531

6.  Cyclin D and cdk4 are required for normal development beyond the blastula stage in sea urchin embryos.

Authors:  Jennifer C Moore; Jan L Sumerel; Bradley J Schnackenberg; Jason A Nichols; Athula Wikramanayake; Gary M Wessel; William F Marzluff
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells.

Authors:  J A Rubiolo; H López-Alonso; M Roel; M R Vieytes; O Thomas; E Ternon; F V Vega; L M Botana
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

8.  Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression.

Authors:  Utsav H Saxena; Christina M H Powell; Jill K Fecko; Roxanne Cacioppo; Hubert S Chou; Geoffrey M Cooper; Ulla Hansen
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

9.  MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway.

Authors:  Ruoxi Hu; Wenchi Pan; Alexey V Fedulov; William Jester; Matthew R Jones; Scott T Weiss; Reynold A Panettieri; Kelan Tantisira; Quan Lu
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

10.  Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.

Authors:  H Jiang; H S Chou; L Zhu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.